Dominion Biotech

Dominion Biotech is a Cheshire-based biotechnology company developing patient-derived cell (PDC) models and assays to support oncology drug discovery and development.

Working in partnership with cancer hospitals and academic collaborators, the company builds a diverse bank of PDC models reflecting the genetic variation seen in clinical cancer populations.

Dominion licenses and develops screening platforms, including an exclusive agreement to commercialise the PredictRx personalised cancer screening service, helping pharmaceutical partners identify optimal chemotherapy treatment protocols.